Holistic Management of 18-Year-Old Female Patients with Bronchial Asthma through a Family Doctor Approach in the Satellite Health Center Area
DOI:
https://doi.org/10.53089/medula.v12i1.408Keywords:
Asthma control, bronchial asthma, family doctor servicesAbstract
Asthma is a chronic inflammation of the airways that causes narrowing of the airways. The prevalence of asthma in Indonesia ranks highest for the category of non-communicable diseases. Asthma is a disease that needs to be controlled to prevent exacerbations and improve the patient's quality of life. Both patients and families are expected to have the knowledge and motivation to make lifestyle modifications so that treatment goals can be achieved, so treatment is needed through a family approach. Primary data were obtained from home visits to complement family data, psychosocial data, and the environment. Secondary data obtained from medical records. Assessment is carried out based on a holistic diagnosis from the beginning, process, and end of the study quantitatively and qualitatively. Patient Mrs. PF is 18 years old, has the main complaint of shortness of breath since 1 day ago. Shortness of breath accompanied by wheezing and coughing, worsening especially at night and early in the morning, cold weather, and after cleaning the house. The patient was diagnosed as bronchial asthma. In this case, diagnosis and treatment have been carried out according to the latest theory and journals. After the intervention, there was a decrease in clinical symptoms and an increase in the knowledge of patients and their families. The diagnosis of bronchial asthma in this patient was in accordance with the theory from several guidelines and journals, it was seen that there was a change in knowledge of the patient and his family after an intervention based on Evidence-Based Medicine that was patient-centred and a family approach.
References
GINA. Global Burden of Asthma. Diakses dari http://www.ginasthma.org/Global-Burden-of-Asthma; 2020.
WHO. Asthma Fact Sheets: World Health Organization; 2019.
Kemenkes RI. Riset Kesehatan Dasar; RISKESDAS. Jakarta: Balitbang Kemenkes RI Perhimpunan Dokter Paru Indonesia; 2018.
Humaidy, Raihan Syarif. Analisis Konsentrasi Eosinofil dan Limfosit Terhadap Kejadian Asma Eksaserbasi Akut Derajat Ringan dan Berat di IGD Rumah Sakit Umum Haji Surabaya. Universitas Muhammadiyah Surabaya; 2020.
Menteri Kesehatan Republik Indonesia. Pedoman Pengendalian Penyakit Asma, dalam Keputusan Menteri Kesehatan Republik Indonesia No. 1023/Menkes/SK/XI. Jakarta: Menteri Kesehatan Republik Indonesia; 2008.
Manurung, Nixson. Hubungan fungsi keluarga di bidang kesehatan terhadap relaps penderita asma bronkial di pantai labu deli serdang. Jurnal Ilmiah Keperawatan IMELDA. Vol. 5, No. 2, September; 2019
Perhimpunan Dokter Paru Indonesia (PDPI). Asma. Pedoman diagnosis & Penatalaksanaan di Indonesia; 2019.
Menteri Kesehatan RI, PERMENKES No. 5 Tahun 2014 Tentang Panduan Praktik Klinis Bagi Dokter di Fasilitas Pelayanan Kesehatan Primer; 2014.
Centers for disease control and prevention. Asthma. Available from:http://www.cdc.gov/asthma/asthmadata.html; 2014.
Purnomo. Faktor Resiko Yang Berpengaruh Terhadap Kejadian Asma Bronkial Pada Anak. Universitas Diponegoro : Semarang; 2008.
Data Rekam Medik RSUD Andi Makkasau Parepare. Laporan SIRS. Pare-pare; 2017.
Wardani, Vani Kusuma. Hubungan Antara Pengetahuan Umum Asma Pasien Dengan Tingkat Kontrol Asma Di RSUD Dr. Moewardi. Skripsi. Surakarta: Universitas Muhammadiyah Surakarta; 2012.
Ekarini, Niluh. Analisis faktor pemicu dominan terjadinya serangan asma pada pasien asma. Tesis. Fakultas Ilmu Keperawatan; 2012.
National Institute for Health and Clinical Excellence. Omalizumab for treating severe persistent allergic asthma (review of technology appraisal guidance 133 and 201). Available at: http://guidance.nice.org.uk/TA278/Guidance/pdf/English; 2013.
Ikawati, Z. Cerdas mengenali obat. Kanisius, Yogyakarta; 2010.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.